Is CORBUS undervalued?
At only 450mcap is Corbus Pharmaceuticals undervalued?
1) Corbus is different from other cannabis stocks as they are designing therapies around marijuana to treat fibrotic diseases. If these therapies work, some analysts put the value of their potential sales at
2BN a year.
2) At a small marketcap of 450m, Corbus could be a real untouched gem in the cannabis industry, compared to its competitors with
4BN+ marketcap.
3) After an agreement with Japananese Kaken Pharmaceutical, Corbus is on the way to receive an additional 173m upon achievement of various milestones
1) Corbus is different from other cannabis stocks as they are designing therapies around marijuana to treat fibrotic diseases. If these therapies work, some analysts put the value of their potential sales at
2BN a year.2) At a small marketcap of 450m, Corbus could be a real untouched gem in the cannabis industry, compared to its competitors with
4BN+ marketcap.3) After an agreement with Japananese Kaken Pharmaceutical, Corbus is on the way to receive an additional 173m upon achievement of various milestones
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.